| abstract |
The present invention relates to Aspergillus niger capable of hydrolyzing plant food allergens, more particularly alpha-amylase/trypsin inhibitors. niger ) to a medicament or dietary supplement capable of treating and/or delaying the onset of diseases due to an innate immune response in humans, including aspergilloglutamic peptidase. The present invention relates to the discovery that Aspergillus niger aspergillus glutamic acid peptidase can hydrolyze alpha-amylase/trypsin inhibitors present in wheat and related grains, these inhibitors being strong inducers of the innate immune response. . Furthermore, the present invention relates to an alpha-amylase comprising the step of incubating a composition for food consumption comprising an alpha-amylase/trypsin inhibitor with Aspergillus nigeraspergilloglutamic acid peptidase, wherein the inhibitor is hydrolyzed. / relates to a method for hydrolyzing a trypsin inhibitor. The invention also relates to an enzyme composition comprising Aspergillus niger aspergillus glutamic acid peptidase and an additional enzyme, and a food product comprising Aspergillus niger aspergillus glutamic acid peptidase. |